Key facts
- It has raised $10.7M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Innovationsstarter, DLB Ventures, German Accelerator, HH Global Partners, YZR Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ApoQlar Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for ApoQlar Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ApoQlar Medical
Developer of a medical mixed reality platform designed to improve medical practices and experience. The company's software platform leverages the hardware to transform medical images, clinical workflows, and medical education into an interactive three-dimensional mixed-reality environment, enabling surgeons to ensure improved patient outcomes and augment the clinical experience for physicians.
- Sector
- Healthcare
- HQ
- Hamburg, Germany
- Founded
- 2017
- Employees
- 60
- Website
- apoqlar.com/
- Ownership
- Privately Held (backing)
ApoQlar Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ApoQlar Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ApoQlar Medical in its N-PORT filings yet. We sweep new filings monthly.